June 18, 2026 Alturos Therapeutics advancement of lead candidate ALT0135, a potentially first-in-class, orally bioavailable small molecule, into IND-enabling studies
June 18, 2026 Endeavour Silver Intersects High-Grade Silver and Gold Mineralization at its Terronera Operation
